Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study Evaluating Effectiveness and Safety of Real-World Treatment With Damoctocog Alfa Pegol in Previously Treated Patients With Hemophilia A

NCT03932201 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03932201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03932201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study Evaluating Effectiveness and Safety of Real-World Treatment With Damoctocog Alfa Pegol in Previously Treated Patients With Hemophilia A
Lead sponsor
Bayer
Phase
Observational
Overall status
Active, not recruiting
Start date
October 21, 2019
Completion date
March 31, 2027
Enrollment
371 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a